In practice, that means a higher risk of severe nausea, vomiting, and GI distress than you had when starting either drug on its own
In this perspective, the qualitative goal of maintaining LBM is increasingly recognised as being as important as quantitative weight loss [23]
At Week 26, the primary HbA1c endpoint was missing for 4.6% and 3.7% of patients randomized to semaglutide tablets 14 mg and empagliflozin 25 mg, respectively
Since 40 units represents a different milligram dose at each concentration, your side effect risk varies accordingly
Tell your doctor about any other medical conditions you may have, especially heart disease, diabetes, blood clotting problems, and adrenal or pituitary gland problems